Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulmatrix (PULM)
NASDAQ:PULM
PULM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.55 - $10.40
Previous CloseN/A
Volume31.27K
Average Volume (3M)35.24K
Market Cap
$36.60M
Enterprise Value-$2.97M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.27
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding3,652,285
10 Day Avg. Volume39,549
30 Day Avg. Volume35,239
Standard Deviation0.30
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.66
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.36
Enterprise Value/Ebitda0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Pulmatrix News
PremiumCompany Announcements
Pulmatrix and Cullgen Announce Strategic Merger Agreement
---
Ownership Overview
―
Insiders
2.01% Mutual Funds
<0.01% Other Institutional Investors
96.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PULM FAQ
What was Pulmatrix’s price range in the past 12 months?
Pulmatrix lowest stock price was $1.55 and its highest was $10.40 in the past 12 months.
What is Pulmatrix’s market cap?
Pulmatrix’s market cap is $36.60M.
When is Pulmatrix’s upcoming earnings report date?
Pulmatrix’s upcoming earnings report date is Mar 27, 2025 which is in 34 days.
How were Pulmatrix’s earnings last quarter?
Pulmatrix released its earnings results on Nov 08, 2024. The company reported -$0.71 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.71.
Is Pulmatrix overvalued?
According to Wall Street analysts Pulmatrix’s price is currently Overvalued.
Does Pulmatrix pay dividends?
Pulmatrix does not currently pay dividends.
What is Pulmatrix’s EPS estimate?
Pulmatrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulmatrix have?
Pulmatrix has 3,652,285 shares outstanding.
What happened to Pulmatrix’s price movement after its last earnings report?
Pulmatrix reported an EPS of -$0.71 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.442%.
Which hedge fund is a major shareholder of Pulmatrix?
Currently, no hedge funds are holding shares in PULM
---
Pulmatrix Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
413.11%
12-Months-Change
Fundamentals
Return on Equity
-62.70%
Trailing 12-Months
Asset Growth
-68.70%
Trailing 12-Months
Company Description
Pulmatrix
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.
---
PULM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Innoviva
―
Vertex Pharmaceuticals
―
Akebia Therapeutics
―
Ardelyx
―
Atea Pharmaceuticals
―
---